Patrizio Lancellotti is the head of the GIGA-Cardiovascular
Despite aspiring to a manual job when he was young,
Patrizio Lancellotti went on to study medicine at the
University of Liège. Once qualified, Patrizio Lancellotti natural-
ly veered towards cardiology. Clinical Head of the CHU at Sart
Tilman, Patrizio Lancellotti had been awarded the Inbev-Baillet
Latour Prize for his clinical research in the field of cardiovas-
cular illness and more specifically for his work on complica-
tions of coronary illnesses.
He is the first European to receive the Tajik/Seward prize from
the Mayo Clinic that rewards the expertise to whom could
demonstrate an exceptional competence in cardiologic care.
Now, he’s the winner of an ERC grant for a five-year project.
The European Research Council (ERC) has announced the
372 winners of its Consolidator Grant competition. These
excellent mid-career scientists are awarded a total of €713
million, as part of the European Union Research and Innovation
programme Horizon 2020. Grants are worth up to €2.75
million each, with an average of €1.91 million per grant. The
funding will enable them to consolidate their research teams
and to develop their most innovative ideas.
On this occasion Carols Moedas, European Commissioner for
Research, Science and Innovation , said : «With every project of
this calibre, we’re making Europe the laboratory of the world.
Our most extraordinary and creative researchers benefit from
EU funding and, in turn, Europe benefits every day from its
investment in knowledge and people
The President of the ERC, Professor Jean-Pierre
Bourguignon, commented : «These Consolidator Grants awar-
ded to 372 research leaders, still in an early stage of their
career, will also back some 1,500 postdocs and PhD students
as team members. This is one more way in which the ERC
is fostering the next generation of bright research talent, and
thereby the human basis for Europe’s competitiveness that
conditions its economic growth